| __timestamp | Corcept Therapeutics Incorporated | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 882000 | 60987000 |
| Thursday, January 1, 2015 | 1361000 | 125542000 |
| Friday, January 1, 2016 | 2058000 | 210460000 |
| Sunday, January 1, 2017 | 3554000 | 275119000 |
| Monday, January 1, 2018 | 5215000 | 409539000 |
| Tuesday, January 1, 2019 | 5504000 | 547758000 |
| Wednesday, January 1, 2020 | 5582000 | 736300000 |
| Friday, January 1, 2021 | 5281000 | 904200000 |
| Saturday, January 1, 2022 | 5385000 | 1080300000 |
| Sunday, January 1, 2023 | 6481000 | 1262200000 |
| Monday, January 1, 2024 | 1530500000 |
Unleashing the power of data
In the ever-evolving landscape of biopharmaceuticals, understanding cost structures is pivotal. Vertex Pharmaceuticals Incorporated and Corcept Therapeutics Incorporated, two industry stalwarts, offer intriguing insights into their financial trajectories from 2014 to 2023.
Vertex Pharmaceuticals has witnessed a remarkable 20-fold increase in its cost of revenue over the past decade, peaking at approximately $1.26 billion in 2023. This growth reflects its aggressive expansion and investment in cutting-edge therapies.
Corcept Therapeutics, while smaller in scale, has shown a steady rise in its cost of revenue, reaching around $6.48 million in 2023. This consistent growth underscores its strategic focus on niche markets.
These trends highlight the contrasting yet successful strategies of these companies, offering valuable lessons in financial management and market positioning.
Cost of Revenue Comparison: Johnson & Johnson vs Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited
Cost of Revenue: Key Insights for Vertex Pharmaceuticals Incorporated and United Therapeutics Corporation
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Viatris Inc.
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Incyte Corporation
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Grifols, S.A.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Insmed Incorporated vs Corcept Therapeutics Incorporated: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Corcept Therapeutics Incorporated vs Dyne Therapeutics, Inc.